August 2, 2024
Via E-mail
Breeyn Handberg, Administrator
Rapid Response Program
Ohio Department of Job & Family Services
Termination: Extended WARN Notice – Letter to Government Officials
Dear Ms. Handberg:
In accordance with the Worker Adjustment and Retraining Notification (“WARN”) Act of 1988, I am
writing on behalf of Xellia Pharmaceuticals USA LLC (“Xellia”) to update our previous correspondence
to you.
On June 17, 2024, you received a letter (copy attached) explaining that, in connection with its
agreement for the sale of its assets (the “Transaction”) to Hikma Pharmaceuticals USA Inc. (“Hikma”),
Xellia anticipated a permanent layoff of approximately 247 U.S. employees (of which 214 work in
Xellia's facility located at 200 Northfield Rd., Bedford OH 44146 (“Bedford OH location”)).
We write to inform you that two who (i) work at the Bedford OH Location and (ii) were previously
expected to be separated on August 17, 2024, are now expected to be separated on October 31,
2024. The affected employees have agreed to assist Xellia with transition services related to
decommissioning in connection with the Transaction.
The affected employees whose separation date have been impacted have been notified and have
been provided with proper updated notifications in accordance with the notice requirements of the
WARN Act. For your information, we have also enclosed a copy of the updated notice we provided
to the affected employees.
For further information, please contact me at 440-999-0940.
Sincerely,
Chris Eckerle, Vice President, Manufacturing Operations North America
Xellia Pharmaceuticals USA LLC
200 Northfield Road
Bedford OH USA 44146
Updated: 8/2/2024 @ 4:56pm